Author at Microdose

Eric Greenbaum

Eric Greenbaum is a scientist and inventor, deeply passionate about improving mental health. For most of the last 10 years Eric was the chief science officer for Vireo Health, a multistate medical cannabis company where he founded and led their R&D team creating more than 70 unique products, filing more than 25 patent applications, and publishing original research in leading scientific journals. Eric is also the founder of NYVR - the largest networking group for virtual reality developers and enthusiasts on the east coast. Eric has a degree in neuroscience from Emory University, a Masters’ degree in pharmacology from UPENN, and a law degree from St. John’s University.

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Health & Wellness

9 Jun 2023

Can Virtual Reality Reduce Costs, Improve Scalability and Access to Psychedelics?

Extended or Virtual Reality platforms deliver psychological support to reduce the burden on therapists, reduce costs, and provide improved patient access...

By Eric Greenbaum

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Follow us on social

Latest News

You Might Also Like

19 Jan 2026

Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative

An industry wide look at how neuroplastogens are reshaping psychedelic medicine in 2026, with insights on Delix, AbbVie’s Gilgamesh acquisition, Enveric, and the shift toward nonhallucinogenic brain therapeutics....

By Madison Roberts

17 Dec 2025

Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward

If 2024 was the year the psychedelic field learned how hard “approval ready” really is, 2025 was the year it began behaving accordingly. The past twelve months were less about...

By Madison Roberts

26 Nov 2025

Delix Therapeutics Reports Strong Phase Ib Results

Delix Therapeutics recently announced compelling data from a Phase Ib trial of DLX-001 (zalsupindole), a non-hallucinogenic neuroplastogen. According to the company’s release, DLX-001 produced robust biomarker signals (quantitative EEG and...

By Madison Roberts

19 Nov 2025

Childhood Trauma’s Role in Men’s Substance Use Disorders

Childhood trauma leaves a deeper imprint on men’s lives than most realize—and for many, it becomes the hidden engine driving substance use disorders. Research shows that emotional abuse, physical violence,...

By Madison Roberts

19 Nov 2025

Human-Centered AI in Healthcare

Artificial intelligence is redefining modern healthcare, offering powerful tools that enhance diagnosis, expedite drug discovery, and enable truly personalized treatment. As health systems struggle with rising costs, aging populations, and...

By Madison Roberts

16 Oct 2025

Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up

As Big Pharma makes billion-dollar bets in the evolving landscape of neuropsychiatric therapeutics, Enveric Biosciences (NASDAQ: ENVB) is carving out a formidable position — not by chasing headlines, but by...

By Madison Roberts

Eric Greenbaum is a scientist and inventor, deeply passionate about improving mental health. For most of the last 10 years Eric was the chief science officer for Vireo Health, a multistate medical cannabis company where he founded and led their R&D team creating more than 70 unique products, filing more than 25 patent applications, and publishing original research in leading scientific journals. Eric is also the founder of NYVR - the largest networking group for virtual reality developers and enthusiasts on the east coast. Eric has a degree in neuroscience from Emory University, a Masters’ degree in pharmacology from UPENN, and a law degree from St. John’s University.

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Follow us on social

WordPress Ads